Blurring Our Edges

Total Page:16

File Type:pdf, Size:1020Kb

Blurring Our Edges NATURE|Vol 450|15 November 2007 BOOKS & ARTS not involve passing on truths from producer rigorous understanding of whose technical between colour perceivers and colour-blind to consumer, but takes the form of fallible expertise really should weigh in on techno- participants, probably because the latter had judgements made in situations in which all logical decision-making. This is what Collins been immersed since birth in the language of the desired information is not available. This and Evans call the “problem of extension”, or colour and acquired the ability to pass as per- applies to scientific collaborations and gov- “who is entitled to contribute to the technical ceivers. In another, judges could not pick out ernmental projects. “The speed of politics,” component of a technological decision”. If an Collins in a group of bona fide gravitational- they write in a characteristically succinct and extension is too technocratic, it will foster dis- wave researchers. clever remark, “exceeds the speed of scientific trust; if it is too broad, there is a risk of invoking These results have startling implications. consensus formation.” This leads them to ‘technological populism’, which means deci- For instance, Evans has shown that minorities defend their seemingly pedestrian conclusion sions could be overly influenced by politics or can acquire enough interactional expertise of that governments should rely on experts as lifestyle choice. mainstream culture to foil attempts to pick “the best way to distil human experience of an The authors address the problem of exten- them out by questioning alone. This suggests uncertain world” — even when those experts sion by offering a “periodic table of expertise” that if minorities live by different values, it is have no final answers. — an attempt “to classify all the types of exper- not through ignorance but choice. The authors needed to defend themselves. tise that might be brought to bear on a techno- Collins and Evans put their points vividly, Some sociologists sharply attacked their 2002 logical problem”. These include about a dozen with elegant language and diagrams. They article on the grounds that the technical and varieties, ranging from language-speaking skills admit that there is more to technological deci- political phases of a controversy cannot be to higher, domain-restricted categories. There is sion-making than “sorting out the appropri- neatly separated, and that governments often ‘contributory’ expertise from active practition- ate groups of experts” and that they are only use expert advice on technical questions (“Does ers of a field (the usual concept of an expert) and addressing the technical phase of public con- activity X meet our standards for safety?”) to ‘interactional’ expertise, which involves fluency troversies. They modestly claim to be only set- disguise political questions (“Should we do in a field in the absence of contribution. Sociol- ting “the ball rolling”. activity X?”). This problem is best met, critics ogists and journalists have interactional exper- Their book starts to lay the groundwork for contended, by expanding public involvement tise, and it is widespread in science (in which solving a critical problem — how to restore the in technological decision-making, breaking scientists must interact across disciplines), in force of technical scientific information in pub- down the boundaries between experts and management and in peer-reviewing. lic controversies, without importing disguised laypeople. Interactional expertise is one of the authors’ political agendas. ■ Rethinking Expertise argues the reverse, most novel ideas. They dramatize it by report- Robert P. Crease is a professor in and chairman namely that disguised political questions ing the results of several Turing-test-like imita- of the Department of Philosophy, Stony Brook would be combated more effectively by a more tion games. In one, judges could not distinguish University, New York 11794, USA. Blurring our edges Enhancing Evolution: The Ethical Case for Making Better People by John Harris Princeton University Press: 2007. 260 pp. $27.95, £16.95 Ending Aging: The Rejuvenation Breakthroughs That Could Reverse Human Aging in Our Lifetime by Aubrey de Grey and Michael Rae St. Martin’s Press: 2007. 400 pp. $26.95 Judy Illes Two new books explore the potential for improving the human condition, one from a medical-ethics viewpoint and the other from a more hands-on biogerontological perspective. Each identifies physical health and cognition as the key areas for attention in the short term, and each speculates on future possibilities for life extension — going well beyond what might be imaginable, or ethical, today. John Harris’s book Enhancing Evolution dis- cusses the future of humankind and of research, and looks at issues such as reproductive choice, designer children and disability. Harris system- atically analyses historical and contemporary writings to support his central claim that the pursuit of methods to enhance the human condition is a moral obligation. His treatment PHOTO NEWS/AP KYODO of opinions by conservative thinkers and phi- Could we all live longer than Japan’s Yone Minagawa, who reached her 114th birthday? 351 BOOKS & ARTS NATURE|Vol 450|15 November 2007 losophers such as Leon Kass, Jürgen Habermas life-prolonging intervention — reconfiguring perhaps will find some traction among those and Francis Fukuyama is at times abrasive. But, the term ‘life sentence’ and introducing new who are more curious than interested in deeper whether or not one agrees with Harris’s posi- systems of justice for the parallel mortal and scientific engagement. I end unconvinced by tion, he dissects their opposing claims with immortal populations? Harris’s view, but my interest was piqued by impressive effectiveness. He makes a persuasive Will people be able to step off the immor- the diverse ways in which physical and mental case that today’s biotechnologies — including tality train when they are ready? Will suicide health, autonomy, culture, and respectful and neuroengineering, stem-cell research and clon- increase if we move life expectancy into the caring community systems can be realized. ing to improve bodies and brains — are on the hundreds? We cannot remove longevity like After we have maximized human well-being continuum of an age-long pursuit by humans a pair of spectacles. And abuse is reported by and compressed morbidity to minimize suf- to improve themselves and therefore, he argues, 1–10% of old people surveyed, mostly directed fering (see A. Kalache et al. Bull. World Health are permissible and morally essential. against women. If society shows increasingly Organ. 80, 243–244; 2002), then let’s think I question the author’s contention that scant regard for centenarians, how will it treat about life extension, step-by-step, one decade choices such as non-medical sex selection can people of 1,000 years old? at a time. ■ be as straightforward as picking a white shirt Let’s not throw away today for tomor- Judy Illes is professor of neurology at the over a Hawaiian one, or that “inevitability is row. Ending Aging is likely to appeal to those National Core of Neuroethics, University of the only reason dying of old age is acceptable”. already converted to the authors’ views, and British Columbia, Vancouver V6T 2B5, Canada. But I do agree that everyone — scientists, ethi- cists and the public — has a role in the research enterprise, not least because of benefit sharing. That is not to say that we should all be drafted Archimedes’ secrets revealed into research, and certainly no end would jus- tify exploitation of children and people with diminished abilities, but service to society by The Archimedes Codex codex, had never been fully deciphered. Access its members is an honourable goal. by Reviel Netz & William Noel to the earliest known version (from the tenth Aubrey de Grey and Michael Rae’s End- Weidenfeld & Nicolson/Phoenix/ century) was important because of a recent shift ing Aging is a more ‘new-wave’ treatment of Da Capo Press: 2007. 336/336/320 pp. in interpretation of Greek texts. The Greeks enhancement, longevity and immortality. £18.99 (hbk)/£8.99/$27.50 (pbk) approached mathematics visually. The diagrams Through chapters with catchy titles, such as and the exact wording used are crucial in under- ‘Putting Zombies to Rest’, and gripping lan- Brian Clegg standing the thinking of a Greek mathematician guage — “I shall look forward to shaking your In April 2004, biologist Lewis Wolpert won — yet when the lost Archimedes manuscripts hand in a future where engineered senescence a debate at the Royal Institution in London were transcribed, no thought was given to cap- is a reality” — the authors call for research that entitled ‘Who was the first scientist?’ He turing the visual nature of the information. will deliver a life expectancy to match that of championed Archimedes. Although I reckon In The Archimedes Codex, Reviel Netz and Methuselah, the oldest of the people whose age Roger Bacon comes closer to deserving that William Noel contribute alternate chapters, (969 years) is mentioned in The Bible. label, the result reflects the respect still felt with Noel describing the history of the codex Ending Aging guides the reader through a for Archimedes’ work. Yet our knowledge and the work undertaken to decipher it, and maze of advances in molecular and cellular of his output has never been complete. The Netz exploring Archimedes’ mathematics. biology that could lead to anti-ageing therapies, Archimedes Codex describes the recent uncov- This discontinuous style is initially unnerving which the authors term SENS (for ‘strategies ering of text from the Archimedes canon not — both authors write in the first person, and it for negligible senescence’). The targets are a read since the parchment forming the codex isn’t clear that the ‘I’ of chapter 1 is not the same range of cancer-causing nuclear and mitochon- was reused to make a prayer book in 1229.
Recommended publications
  • Chapter 6: Old People Are People Too, So Let's Act
    Career Planning & Adult Development JOURNAL Volume 31, Number 2 ISSN 0736-1920 Summer 2015 OUR FUTURE: Projections of Work and Life Helen Harkness, Guest Editor QThe Future Q The End of Work as We Know It QJobs and Careers on the Front Line of the Future QSilicon Valley and the New Rules of Work Q Training Challenges Facing Education and Training and Career Development in the Future QOld people are people too, so let’s act accordingly Q Crisis of Human Capital in Aerospace: It’s All About the STEM QCollege for All – Reality or Flawed Myth? QOur Jobs: The American Workforce and Economy in Crisis Q The Future Has Arrived: The Future is Now the Present Summer 2015..............................Career Planning and Adult Development JOURNAL..............................1 CAREER PLANNING and ADULT DEVELOPMENT JOURNAL Volume 31, Number 2 ISSN 0736-1920 Summer 2015 OUR FUTURE: Projections of Work and Life Looking Ahead with the Journal,E\Steven E. Beasley, Managing Editor4 Introduction to this Issue, E\ Helen Harkness, PhD, Guest Editor5 Chapter 1: 7KH)XWXUHE\ Leigh Ellen Key8 Chapter 2: 7KH(QGRI:RUNDV:H.QRZ,Wby Andy Hines10 Chapter 3: -REVDQG&DUHHUVRQWKH)URQW/LQHRIWKH)XWXUHby Gary Marx20 Chapter 4: 6LOLFRQ9DOOH\DQGWKH1HZ5XOHVRI:RUNE\Gary A. Bolles28 Chapter 5: 7UDLQLQJ&KDOOHQJHV)DFLQJ(GXFDWLRQDQG7UDLQLQJ DQG&DUHHU'HYHORSPHQWLQWKH)XWXUHE\Timothy C. Mack40 Chapter 6: 2OGSHRSOHDUHSHRSOHWRRVROHW·VDFWDFFRUGLQJO\by Aubrey de Grey47 Chapter 7: &ULVLVRI+XPDQ&DSLWDOLQ$HURVSDFH,W·V$OO$ERXWWKH67(0 by Deborah Westphal51 Chapter 8: &ROOHJHIRU$OO²5HDOLW\RU)ODZHG0\WK"E\
    [Show full text]
  • Who Wants to Live Forever? Reader’S Digest
    HEALTH Who Wantsto Live Forever? As a species, we humans appear to be the undisputed masters of our planet. Moreover, since Yuri Gagarin’s inaugural space flight in 1961, we can even leave the confines of Earth to travel in space. Yet, we have one Achilles’ heel—we’re mortal BY CHRIS MENON 1234567890 1234567890 36 BRAIN LIGHT/ALAMY STOCK PHOTO WHO WANTS TO LIVE FOREVER? READEr’s DIGEST T 122 YEARS, THE MAXIMUM HUMAN LIFESPAN lags well behind some species of giant tortoise (188 years), Greenland shark (400 years) and the record set by the lowly Icelandic clam (507 years). Even those relatively few humans who do manage to make it past 100—some 14,570 people in the UK in 2015—are invariably bedeviled byA poor health. Recently, efforts to extend the healthy of Amazon, has similarly invested human lifespan have achieved much in Unity Biotechnology, which aims publicity following the backing of “to design therapeutics that prevent, visionary, super-rich Silicon Valley halt, or reverse diseases of ageing”. tech entrepreneurs. In 2013, Google’s Unity intends to develop a new founders created a subsidiary class of therapies called “senolytic company called Calico (short for medicines”, designed to selectively the California Life Company), eliminate senescent cells. Senescent Billionaire researchers, which promptly hired a team of top cells accumulate with age and, Some believe that death, Arthur Levinson, Jeff technologies that scientists and now has more than unlike normal cells, they secrete like any disease, can be Bezos and Elon Musk the SENS Research £1bn in the bank to fund its work.
    [Show full text]
  • From Here to Immortality: Anti-Aging Medicine
    FromFrom HereHere toto Immortality:Immortaalitty: AAnti-AgingAnnntti-AAgging MMedicineedicine Anti-aging medicine is a $5 billion industry. Despite its critics, researchers are discovering that inter ventions designed to turn back time may prove to be more science than fiction. By Trudie Mitschang 14 BioSupply Trends Quarterly • October 2013 he symptoms are disturbing. Weight gain, muscle Shifting Attitudes Fuel a Booming Industry aches, fatigue and joint stiffness. Some experience The notion that aging requires treatment is based on a belief Thear ing loss and diminished eyesight. In time, both that becoming old is both undesirable and unattractive. In the memory and libido will lapse, while sagging skin and inconti - last several decades, aging has become synonymous with nence may also become problematic. It is a malady that begins dete rioration, while youth is increasingly revered and in one’s late 40 s, and currently 100 percent of baby boomers admired. Anti-aging medicine is a relatively new but thriving suffer from it. No one is immune and left untreated ; it always field driven by a baby- boomer generation fighting to preserve leads to death. A frightening new disease, virus or plague? No , its “forever young” façade. According to the market research it’s simply a fact of life , and it’s called aging. firm Global Industry Analysts, the boomer-fueled consumer The mythical fountain of youth has long been the subject of base will push the U.S. market for anti-aging products from folklore, and although it is both natural and inevitable, human about $80 billion now to more than $114 billion by 2015.
    [Show full text]
  • Read Our New Annual Report
    The seeds of a concept. The roots of an idea. The potential of a world free of age-related disease. Photo: Sherry Loeser Photography SENS Research Foundation Board of Directors Barbara Logan, Chair Bill Liao, Secretary Kevin Perrott, Treasurer Michael Boocher Jonathan Cain Kevin Dewalt Michael Kope Jim O’Neill Frank Schüler Sherry Loeser Photography 2 Contents CEO Letter (Jim O’Neill) 4 Finances 5 Donors 6 - 7 Fundraising & Conferences 8 - 9 Around the World with Aubrey de Grey 10 Outreach 11 Founding CEO Tribute & Underdog Pharmaceuticals 12 - 13 Investments 14 Welcome New Team Members 15 Education 16 - 17 Publications & Research Advisory Board 18 Research Summaries 19 - 22 Ways to Donate 23 The SRF Team Front row: Anne Corwin (Engineer/Editor), Amutha Boominathan (MitoSENS Group Lead), Alexandra Stolzing (VP of Research), Aubrey de Grey (Chief Science Officer), Jim O’Neill (CEO), Bhavna Dixit (Research Associate). Center row: Caitlin Lewis (Research Associate), Lisa Fabiny-Kiser (VP of Operations), Gary Abramson (Graphics), Maria Entraigues-Abramson (Global Outreach Coordinator), Jessica Lubke (Administrative Assistant). Back row: Tesfahun Dessale Admasu (Research Fellow), Amit Sharma (ImmunoSENS Group Lead), Michael Rae (Science Writer), Kelly Protzman (Executive Assistant). Not Pictured: Greg Chin (Director, SRF Education), Ben Zealley (Website/Research Assistant/ Deputy Editor) Photo: Sherry Loeser Photography, 2019 3 From the CEO At our 2013 conference at Queens College, Cambridge, I closed my talk by saying, “We should not rest until we make aging an absurdity.” We are now in a very different place. After a lot of patient explanation, publication of scientific results, conferences, and time, our community persuaded enough scientists of the feasibility of the damage repair approach to move SENS and SENS Research Foundation from the fringes of scientific respectability to the vanguard of a mainstream community of scientists developing medical therapies to tackle human aging.
    [Show full text]
  • Longevity and Generosity. the Death of Death. July 2018. N° 112
    Longevity and generosity. The death of death. July 2018. N° 112. Some people say, “Oh, you shouldn’t do enhancement” but the thing is we do enhancement all the time — to some extent, all aging reversal is enhancement. ​ ​ ​ ​ Vaccines are enhancement… I think I’m just now getting up to speed after 63 years of education. Aging reversal is something that will buy me and many of my colleagues a lot more time to make many more contributions, so you might consider that a meta-level contribution, if we can pull that off. World-renowned ​ Harvard University biology researcher George Church (source). ​ ​ ​ ​ Theme of the month. How to contribute financially to research for a much longer healthy life Introduction If you have considerable financial means you can afford medical care more easily than less well-off citizens. But whether you are rich or not, with a good "genetic capital" or not, whatever your precautions and your anti-aging clinic visits, in the current state of knowledge your chances are low of living more than 100 years if you are a woman and beyond 95 years if you are of the weaker sex for longevity. And whatever happens, you will not live past 122 years for a ​ ​ woman et 116 years for a man. ​ ​ To go further will require complex and costly research. If informed citizens pay money to support this research, it will be positive in a direct way by funding the research. It will also be positive in that it will show the growing interest in these issues. What could you do about it? Moderate financial support If your financial means are limited or if you do not wish to make large donations, your action can still have an impact.
    [Show full text]
  • Ÿþc R Y O N I C S M a G a Z I N E , Q 1 2 0
    2007 RECAP 1st Quarter 2008 • Volume 29:1 2007 ANnual Review page 5 Member Profile: Wes Du Charme page 3 7th Alcor Conference Recap page 13 Cryonics and Religion: Friends or Foes? page 19 INSIDE CRYONICS 2 From the Editor 1ST QUARTER 2008 • VOLUME 29:1 19 Cryonics and Religion: Friends or Foes? The cryonics community recognizes the importance and challenge of being 1st Quarter 2008 • Volume 29:1 understood by the general 2007 RECAP public. Religion plays a sub- Cover shows opening reception stantial role in our diverse at the 7th Alcor conference. 2007 ANnual society and may seem to Review Photo by Brian Harris. page 5 some to be at odds with many facets of scientific COVER STORY: PAGE 5 advancement. Meet one theologian who feels the 2007 Annual Review: Today, over ultimate success of cryonics 850page people 3 in the world rely on the is contingent upon the sup- Member Profile: Wes Du CharmeAlcor Life Extension Foundation for Recap port of more than just great Conferencecryopreservation page 13 services. Enrich your 7th Alcor scientific minds. understanding of present-day clinical advancements with the potential to CryonicsFriends and Religion: or Foes?page 19 significantly benefit Alcor’s growing 22 Book Review: Ending membership base in years to come. Aging Likened to a good detective novel, Ending Aging allures the reader into a real- life tale of the mysteries of aging. The author, Dr. 3 Member Profile: Wes Du Charme Aubrey de Grey, has been Wes Du Charme – psychologist, author and barber shop quartet the center of controversy singer – celebrates his thirteenth year as an Alcor member in since proposing a systematic June 2008.
    [Show full text]
  • SENS Research Foundation Annual Report 2015
    S E N S R e s e a r c h F o u n d a t i o n has a unique mission: to ensure the development of cures which repair the underlying cellular and molecular damage of aging. This document, our 2 0 1 5 R e p o r t, demonstrates our commitment to delivering on the promise of that mission, and to meeting the challenges facing the rapidly emerging rejuvenation biotechnology field. Our research program delivers key proof-of-concept results. Our education program prepares the first generation of rejuvenation biotechnology professionals. Our outreach program widens and connects our communi. Our Rejuvenation Biotechnology conferences unite stakeholders from academic, industrial, political, regulatory and financial institutions. Together, we are transforming the way the world researches and treats age-related disease. i n t r o d u c t i o n 2 l e t t e r f r o m t h e C E O 3 c o m m u n i t y 4 o u t r e a c h 6 e d u c a t i o n 8 r e s e a r c h 1 0 f i n a n c e s 1 4 r e s e a r c h : p r o j e c t b y p r o j e c t 1 5 s u p p o r t i n g t h e f o u n d a t i o n 2 3 FOUNDATION BOARD OF LEADERSHIP DIRECTORS Mike Kope Barbara Logan Jonathan Cain Chief Executive Officer Board Chair Kevin Dewalt Kevin Perrott Dr.
    [Show full text]
  • Why We Should Reject Radical Enhancement.1
    A peer-reviewed electronic journal published by the Institute for Ethics and Emerging Technologies ISSN 1541-0099 21(2) - November 2010 Thoughts about our species’ future: themes from Humanity’s End: Why We Should Reject Radical Enhancement.1 Nicholas Agar Philosophy, Victoria University of Wellington [email protected] Journal of Evolution and Technology - Vol. 21 Issue 2 – November 2010 - pgs 23-31 http://jetpress.org/agar.htm Abstract This paper summarizes a couple of the main arguments from my new book, Humanity’s End. In the book I argue against radical enhancement – the adjustment of human attributes and abilities to levels that greatly exceed what is currently possible for human beings. I’m curious to see what reaction this elicits in a journal whose readership includes some of radical enhancement’s most imaginative and committed advocates. Humanity’s End is motivated by the conviction that the debate about human enhancement must move beyond the binary “yes, I love it; no, it’s evil” dialectic that has tended to dominate philosophical discussion up till now. When we focus on the multiple means – cybernetic, genetic, nanotechnological, and so on – by which humans are likely to be enhanced, we find significant moral differences. Some human enhancements should be endorsed; many should be rejected. An additional motivation for Humanity’s End is a sense that the technologies of human enhancement are on the verge of something really big. If Ray Kurzweil is right, then improvements of the information technologies that may be used to enhance human attributes track an exponential path (Kurzweil 2005).
    [Show full text]
  • Do Actuaries Believe in Longevity Deceleration? Edouard Debonneuil, Stéphane Loisel, Frédéric Planchet
    Do actuaries believe in longevity deceleration? Edouard Debonneuil, Stéphane Loisel, Frédéric Planchet To cite this version: Edouard Debonneuil, Stéphane Loisel, Frédéric Planchet. Do actuaries believe in longevity decelera- tion?. 2015. hal-01219270v2 HAL Id: hal-01219270 https://hal.archives-ouvertes.fr/hal-01219270v2 Preprint submitted on 5 Aug 2017 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. DO ACTUARIES BELIEVE IN LONGEVITY DECELERATION? Edouard Debonneuil Stéphane Loisel Frédéric Planchet* Univ Lyon - Université Claude Bernard Lyon 1, ISFA, Laboratoire SAF EA2429, F-69366, Lyon, France Prim’Act, 42 avenue de la Grande Armée, 75017 Paris, France ActuRx Version 2.0 du 05/08/2017 ABSTRACT As more and more people believe that significant life extensions may come soon, should commonly used future mortality assumptions be considered prudent? We find here that commonly used actuarial tables for annuitants – as well as the Lee-Carter model – do not extrapolate life expectancy at the same rate for future years as for past years; instead they produce some longevity deceleration. This is typically because their mortality improvements decrease after a certain age, and those age-specific improvements are constant over time.
    [Show full text]
  • Sample Chapter [PDF]
    THE PHILOSOPHY OF TRANSHUMANISM This page intentionally left blank THE PHILOSOPHY OF TRANSHUMANISM ACriticalAnalysis BENJAMIN ROSS University of North Texas, USA United Kingdom – North America – Japan – India Malaysia – China Emerald Publishing Limited Howard House, Wagon Lane, Bingley BD16 1WA, UK First edition 2020 © 2020 Benjamin Ross Published under exclusive licence by Emerald Publishing Limited Reprints and permissions service Contact: [email protected] No part of this book may be reproduced, stored in a retrieval system, transmitted in any form or by any means electronic, mechanical, photocopying, recording or otherwise without either the prior written permission of the publisher or a licence permitting restricted copying issued in the UK by The Copyright Licensing Agency and in the USA by The Copyright Clearance Center. Any opinions expressed in the chapters are those of the authors. Whilst Emerald makes every effort to ensure the quality and accuracy of its content, Emerald makes no representation implied or otherwise, as to the chapters’ suitability and application and disclaims any warranties, express or implied, to their use. British Library Cataloguing in Publication Data A catalogue record for this book is available from the British Library ISBN: 978-1-83982-625-2 (Print) ISBN: 978-1-83982-622-1 (Online) ISBN: 978-1-83982-624-5 (Epub) CONTENTS Introduction 1 1. Redesigning Humans 5 1.1. Transhumanist Philosophy I: Summoning the Posthuman 7 1.2. Transhumanist Philosophy II: Epistemological Certainty 13 1.3. Resisting Transhumanism: Bioconservative Views 18 1.4. The Language of Enhancement through the Lens of Automation 25 2. Engaging with Transhumanism 37 2.1.
    [Show full text]
  • SENS Research Foundation Annual Report 2014
    sens research foundation foundation report august 2014 mission 2 leer from the CEO 3 outreach 4 research 8 education 14 finances 16 research: project by project 18 FOUNDATION BOARD OF LEADERSHIP DIRECTORS Mike Kope Barbara Logan Jonathan Cain Chief Executive Officer Board Chair Kevin Dewalt Kevin Perrott Aubrey de Grey Treasurer James O’Neill Chief Science Officer Bill Liao Mike Kope Secretary © 2014, SENS Research Foundation a: 110 Pioneer Way, Suite J / Mountain View, CA 94041 / USA p: 650.336.1780 f: 650.336.1781 www.sens.org All rights reserved. No part of this material may be reproduced without specific permission from SENS Research Foundation. SENS Research Foundation’s federal employer ID number is 94-3473864. Because SENS Research Foundation is a 501(c)(3) non-profit, your donation may be tax deductible. transforming the way the world researches and treats age-related disease We fund research at institutions around the world, and at our own Moun- tain View facility. Our research is integrated with wide-ranging outreach and education programs. Our goal is to see the emergence of an industry that will cure the diseases of aging, an industry based around what we call rejuvenation biotechnology. Many things go wrong with aging bodies, but at the root of them all is the burden of decades of unrepaired damage to the cellular and molecular structures that make up the functional units of our tissues. Faced with the diseases and disabilities caused by this damage, today’s medicine is too often reduced to crisis management in the emergency room, painfully harsh treatments for diseases such as cancer, or best efforts at palliative care.
    [Show full text]
  • Life Extension Pseudoscience and the SENS Plan
    Life Extension Pseudoscience and the SENS Plan Preston W. Estep III, Ph.D. President and CEO, Longenity Inc. Matt Kaeberlein, Ph.D. Department of Pathology University of Washington Pankaj Kapahi, Ph.D. Buck Institute for Age Research Brian K. Kennedy, Ph.D. Department of Biochemistry University of Washington Gordon J. Lithgow Ph.D. Buck Institute for Age Research George M. Martin, M.D. Department of Pathology University of Washington Simon Melov, Ph.D. Buck Institute for Age Research R. Wilson Powers III Department of Genome Sciences University of Washington Heidi A. Tissenbaum, Ph.D. Program in Gene Function and Expression Program in Molecular Medicine University of Massachusetts Medical School Abstract Recent scientific advances have taken gerontological research to challenging and exciting new frontiers, and have given many scientists increased confidence that human aging is to some degree controllable. We have been on the front lines of some of these developments and the speculative discussions they have engendered, and we are proud to be part of the increasingly productive biomedical effort to reduce the pathologies of aging, and age-associated diseases, to the greatest degree possible—and to extend healthy human life span to the greatest degree possible. In contrast to clearly justifiable speculations regarding future advances in human longevity a few have made claims that biological immortality is within reach. One, Aubrey de Grey, claims to have developed a “detailed plan to cure human aging” called Strategies for Engineered Negligible Senescence (SENS) [1, 2]. This is an extraordinary claim, and we believe that extraordinary claims require extraordinary evidentiary support. In supplementary material posted on the Technology Review web site we evaluate SENS in detail.
    [Show full text]